Tabunda, Baby Girl .
HRN: 23-17-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
AMPICILLIN 250MG (VIAL)
06/12/2023
06/18/2023
IV
80
Q12
Sepsis Neonatarum
Waiting Final Action
06/14/2023
CEFOTAXIME 500MG (VIAL)
06/14/2023
06/20/2023
IV
80mg
Q12
Neonatal Sepsis
Waiting Final Action